ConditionMelanoma (Skin Cancer)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Basel, Switzerland
About this trial
This study aims to generate evidence on patient and dermatologist perspectives regarding two total body photography systems. Patient and clinician preferences represent key factors in healthcare decision-making. The investigation will also provide data on the time efficiency of each system in a real-world setting.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Signed informed consent by the participant
Sufficient proficiency in German
Previous melanoma (including in situ)
Disqualifiers
Lack of informed consent
Immobility. (Patients must be able to stand without support for 30 minutes.)
Inability to follow the procedures of the investigation, including inability to follow on-screen instructions or to read (e.g. due to visual impairment or cognitive impairment)
Vulnerable Subjects
Trial design
Treatments tested in this trial
- Deviskan
- Vectra WB360
- Standard-of-care clinical examinations
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov